These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10892665)

  • 21. Importance of myocardial ischaemia for recruitment of coronary collateral circulation in dogs.
    Yamanishi K; Fujita M; Ohno A; Sasayama S
    Cardiovasc Res; 1990 Apr; 24(4):271-7. PubMed ID: 2346962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of atrial natriuretic peptide on coronary collateral blood flow.
    Foreman B; Dai XZ; Homans DC; Laxson DD; Bache RJ
    Circ Res; 1989 Dec; 65(6):1671-8. PubMed ID: 2531047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sevoflurane selectively increases coronary collateral blood flow independent of KATP channels in vivo.
    Kersten JR; Schmeling T; Tessmer J; Hettrick DA; Pagel PS; Warltier DC
    Anesthesiology; 1999 Jan; 90(1):246-56. PubMed ID: 9915334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sympathetic influences on the native canine coronary collateral circulation.
    Euler DE
    Cardiovasc Res; 1995 Jan; 29(1):33-7. PubMed ID: 7895236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene C4.
    Wargovich T; Mehta J; Nichols WW; Pepine CJ; Conti CR
    J Am Coll Cardiol; 1985 Nov; 6(5):1047-51. PubMed ID: 4045029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in collateral blood flow produced by isoflurane in a chronically instrumented canine model of multivessel coronary artery disease.
    Hartman JC; Kampine JP; Schmeling WT; Warltier DC
    Anesthesiology; 1991 Jan; 74(1):120-33. PubMed ID: 1986637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acadesine increases blood flow in the collateralized heart during exercise.
    Ishibashi Y; Quebbeman BB; Duncker DJ; Klassen C; Bache RJ
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):552-61. PubMed ID: 9781923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of isoflurane and halothane on coronary vascular resistance and collateral myocardial blood flow: their capacity to induce coronary steal.
    Cason BA; Verrier ED; London MJ; Mangano DT; Hickey RF
    Anesthesiology; 1987 Nov; 67(5):665-75. PubMed ID: 3674466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic effects of LTC4 and TxA2 on coronary flow and myocardial function.
    Nichols WW; Mehta JL; Thompson L; Donnelly WH
    Am J Physiol; 1988 Jul; 255(1 Pt 2):H153-9. PubMed ID: 3394816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitroglycerin dilates coronary collateral vessels during exercise after blockade of endogenous NO production.
    Klassen CL; Traverse JH; Bache RJ
    Am J Physiol; 1999 Sep; 277(3):H918-23. PubMed ID: 10484411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasomotor activity of moderately well-developed canine coronary collateral circulation.
    Hautamaa PV; Dai XZ; Homans DC; Bache RJ
    Am J Physiol; 1989 Mar; 256(3 Pt 2):H890-7. PubMed ID: 2466413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasomotor responses of newly developed coronary collateral vessels.
    Kinn JW; Altman JD; Chang MW; Bache RJ
    Am J Physiol; 1996 Aug; 271(2 Pt 2):H490-7. PubMed ID: 8770088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitric oxide inhibition impairs blood flow during exercise in hearts with a collateral-dependent myocardial region.
    Traverse JH; Kinn JW; Klassen C; Duncker DJ; Bache RJ
    J Am Coll Cardiol; 1998 Jan; 31(1):67-74. PubMed ID: 9426020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Creation of anastomoses between an extracardiac artery and the coronary circulation. Proof that myocardial angiogenesis occurs and can provide nutritional blood flow to the myocardium.
    Unger EF; Sheffield CD; Epstein SE
    Circulation; 1990 Oct; 82(4):1449-66. PubMed ID: 1698130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of nicorandil, a new antianginal agent, and nifedipine on collateral blood flow in a chronic coronary occlusion model.
    Lamping KA; Warltier DC; Hardman HF; Gross GJ
    J Pharmacol Exp Ther; 1984 May; 229(2):359-63. PubMed ID: 6232374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protamine inhibits coronary collateral development in a canine model of repetitive coronary occlusion.
    Kersten JR; Pagel PS; Warltier DC
    Am J Physiol; 1995 Feb; 268(2 Pt 2):H720-8. PubMed ID: 7532374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cardioprotective effects of the thromboxane receptor antagonist SQ 30,741 are not reversed by aspirin.
    Grover GJ; Parham CS; Schumacher WA
    Basic Res Cardiol; 1991; 86(2):99-106. PubMed ID: 1831610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs.
    Tanabe M; Terashita Z; Nishikawa K; Hirata M
    J Cardiovasc Pharmacol; 1984; 6(3):442-8. PubMed ID: 6202970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of beta-adrenergic receptor blockade on blood flow to collateral-dependent myocardium during exercise.
    Traverse JH; Altman JD; Kinn J; Duncker DJ; Bache RJ
    Circulation; 1995 Mar; 91(5):1560-7. PubMed ID: 7867199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropeptide Y and coronary vasoconstriction: role of thromboxane A2.
    Martin SE; Kuvin JT; Offenbacher S; Odle BM; Patterson RE
    Am J Physiol; 1992 Oct; 263(4 Pt 2):H1045-53. PubMed ID: 1415751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.